LSBCF (LakeShore Biopharma Co) Total Current Assets: $116.18 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Total Current Assets?

LakeShore Biopharma Co LSBCF Total Current Assets is $116.18 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. LakeShore Biopharma Co's total current assets for the quarter that ended in Mar. 2025 was $116.18 Mil.

LakeShore Biopharma Co  (OTCPK:LSBCF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

LakeShore Biopharma Co's Liquidation Value for the quarter that ended in Mar. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=3.874-119.723+0.75 * 69.099+0.5 * 31.395
=-48.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Current Assets Related Terms

LakeShore Biopharma Co Total Current Assets Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Current Assets Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Current Assets
112.61 120.54 150.34 125.41 116.18

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Current Assets Get a 7-Day Free Trial Premium Member Only 150.34 128.07 125.41 120.45 116.18

LakeShore Biopharma Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

LakeShore Biopharma Co's Total Current Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=3.874+69.219+31.395+11.691
=116.18

LakeShore Biopharma Co's Total Current Assets for the quarter that ended in Mar. 2025 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=3.874+69.219+31.395+11.691
=116.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of $116.18 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Total Current Assets of $116.18 Mil as of Mar. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Current Assets too high?
LakeShore Biopharma Co's current Total Current Assets is $116.18 Mil.
How does LakeShore Biopharma Co's Total Current Assets compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Current Assets of $116.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Current Assets is $116.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Current Assets of $116.18 Mil. The current Total Current Assets is $116.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Current Assets is $116.18 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.